<table id="table11" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 11  Development of Resistance to MVC or EFV and Background Drugs in Antiretroviral Treatment-Naïve Trial A4001026 for Patients with CCR5-tropic Virus at Screening using Enhanced Sensitivity Trofile® Assay</caption>
<col align="right" valign="top" width="40%"></col>
<col align="center" valign="top" width="30%"></col>
<col align="center" valign="top" width="30%"></col>
<thead>
<tr>
<th stylecode="Lrule Rrule"></th>
<th stylecode="Rrule">MVC</th>
<th stylecode="Rrule">EFV</th>
</tr>
</thead>
<tbody>
<tr stylecode="Botrule">
<td align="left" stylecode="Lrule Rrule">Total N in Dataset<br/>(As-Treated)</td>
<td stylecode="Rrule">273</td>
<td stylecode="Rrule">241</td>
</tr>
<tr stylecode="Botrule">
<td align="left" stylecode="Lrule Rrule">Total Virologic Failures (As-Treated)</td>
<td stylecode="Rrule">85(31%)</td>
<td stylecode="Rrule">56 (23%)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Evaluable Virologic Failures with Post Baseline Genotypic and Phenotypic Data</td>
<td stylecode="Rrule">73</td>
<td stylecode="Rrule">43</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">•  Lamivudine Resistance</td>
<td stylecode="Rrule">39 (53%)</td>
<td stylecode="Rrule">13 (30%)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">•  Zidovudine Resistance</td>
<td stylecode="Rrule">2 (3%)</td>
<td stylecode="Rrule">0</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">•    Efavirenz Resistance</td>
<td stylecode="Rrule">--</td>
<td stylecode="Rrule">23 (53%)</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">•  Phenotypic Resistance to MVC<footnote>Includes subjects failing with CXCR4- or dual/mixed-tropism because these viruses are not intrinsically susceptible to maraviroc.</footnote>
</td>
<td stylecode="Rrule">19 (26 % )</td>
<td stylecode="Rrule"></td>
</tr>
</tbody>
</table>